Variant report
Variant | esv3349313 |
---|---|
Chromosome Location | chr7:109745050-109760395 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:109750040..109751863-chr7:109755032..109756832,2 | MCF-7 | breast: | |
2 | chr7:109750645..109752483-chr7:109755448..109757268,2 | K562 | blood: | |
3 | chr7:109750645..109752483-chr7:109755448..109757268,2 | K562 | blood: | |
4 | chr7:109750040..109751863-chr7:109755032..109756832,2 | MCF-7 | breast: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-IMMP2L-6 | chr7:109748142-109748387 | NONHSAT122759 |
2 | lnc-IMMP2L-6 | chr7:109750710-109750732 | NONHSAT122759 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs528935651 | chr7:109745051-109745052 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs185268414 | chr7:109745072-109745073 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs141253874 | chr7:109745091-109745092 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs73199886 | chr7:109745102-109745103 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs532812301 | chr7:109745106-109745107 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs531358317 | chr7:109745138-109745139 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs190183598 | chr7:109745143-109745144 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs552437360 | chr7:109745157-109745158 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs553912544 | chr7:109745160-109745161 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs529584934 | chr7:109745161-109745162 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs12533760 | chr7:109745209-109745210 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs111354145 | chr7:109745210-109745211 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs537842752 | chr7:109745211-109745212 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs550058827 | chr7:109745254-109745255 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs551900078 | chr7:109745280-109745281 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs181409277 | chr7:109745307-109745308 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs185983807 | chr7:109745332-109745333 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs75746933 | chr7:109745362-109745363 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs573599381 | chr7:109745372-109745373 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536099709 | chr7:109745378-109745379 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs556172324 | chr7:109745457-109745458 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs562732784 | chr7:109745461-109745462 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs568645512 | chr7:109745502-109745503 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs191960920 | chr7:109745504-109745505 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565025965 | chr7:109745508-109745509 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs572135187 | chr7:109745509-109745510 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs148475002 | chr7:109745514-109745515 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs560623529 | chr7:109745683-109745684 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs142357853 | chr7:109745727-109745728 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs549691383 | chr7:109745818-109745819 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs78633032 | chr7:109745859-109745860 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs373994516 | chr7:109745890-109745891 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs531762817 | chr7:109745903-109745904 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs75373390 | chr7:109745913-109745914 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs2692413 | chr7:109745944-109745945 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs367686834 | chr7:109746002-109746003 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs77490996 | chr7:109746005-109746006 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs60336867 | chr7:109746050-109746051 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs542787334 | chr7:109746054-109746055 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs534004094 | chr7:109746110-109746111 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs547196330 | chr7:109746162-109746163 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs567162871 | chr7:109746188-109746189 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs1404851 | chr7:109746201-109746202 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs4446679 | chr7:109746283-109746284 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs4521700 | chr7:109746301-109746302 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs556447656 | chr7:109746306-109746307 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs576242176 | chr7:109746336-109746337 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs75225829 | chr7:109746340-109746341 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs538641706 | chr7:109746349-109746350 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs184223940 | chr7:109746363-109746364 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Breast cancer | 16397240 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Autism | 19401682 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
small cell lung cancer | 20016488 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:109739200-109755800 | Weak transcription | Dnd41 | blood |
2 | chr7:109744200-109745400 | Enhancers | Brain Germinal Matrix | brain |
3 | chr7:109745200-109745800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr7:109745200-109746000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr7:109745400-109745600 | Flanking Active TSS | Brain Germinal Matrix | brain |
6 | chr7:109745400-109745800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr7:109745400-109746000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr7:109745400-109746200 | Enhancers | HMEC | breast |
9 | chr7:109745400-109746600 | Enhancers | NHEK | skin |
10 | chr7:109745600-109745800 | Active TSS | Brain Germinal Matrix | brain |
11 | chr7:109746000-109747000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
12 | chr7:109746200-109747200 | Weak transcription | HMEC | breast |
13 | chr7:109746600-109748400 | Weak transcription | NHEK | skin |
14 | chr7:109747000-109749000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
15 | chr7:109747200-109747400 | Enhancers | HMEC | breast |
16 | chr7:109748400-109748800 | Enhancers | NHEK | skin |
17 | chr7:109755800-109756400 | Strong transcription | Dnd41 | blood |
18 | chr7:109756400-109766600 | Weak transcription | Dnd41 | blood |
19 | chr7:109758400-109760200 | Enhancers | Brain Germinal Matrix | brain |
20 | chr7:109759400-109759600 | Enhancers | Pancreas | Pancrea |
21 | chr7:109759600-109768000 | Weak transcription | Pancreas | Pancrea |
22 | chr7:109759800-109760200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |